Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2025 Earnings Call Transcript November 3, 2025
Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.34.
Operator: Good afternoon, and welcome to Castle Biosciences’ Third Quarter 2025 Conference Call. As a reminder, today’s call is being recorded. [Operator Instructions] I would like to turn the call over to Camilla Zuckero, Vice President, Investor Relations and Corporate Affairs. Please go...
